1

2
Noriko Oku legal representative, Chikako Oku legal representative, Tomohito Oku legal representative, Hiroshi Kayakiri, Yoshito Abe, Hitoshi Hamashima, Hitoshi Sawada, Naoki Ishibashi, Hiroyuki Setoi, Noritsugu Yamasaki, Takafumi Imoto, Takahiro Hiramura: Imidazole compounds and medicinal use thereof. Fujisawa Pharmaceutical, Oblon Spivak McClelland Maier & Neustadt P C, June 13, 2006: US07060721 (39 worldwide citation)

Imidazole compounds represented by general formula (I): wherein each symbol is as defined in the specification, and salts thereof, and a pharmaceutical composition containing same are provided. These compounds are useful in treating the diseases curable based on a hypoglycemic action, and the diseas ...


3

4

5

6
Hiroshi Kayakiri, Yoshito Abe, Hitoshi Hamashima, Hitoshi Sawada, Tsuyoshi Mizutani, Teruo Oku, Noritsugu Yamasaki, Osamu Onomura, Masahiro Nishikawa, Takahiro Hiramura, Takafumi Imoto: Sulfonamide compounds and pharmaceutical use thereof. Fujisawa Pharmaceutical, Oblon Spivak McClelland Maier & Neustadt P C, June 28, 2005: US06911469 (5 worldwide citation)

A sulfonamide compound of the formula (I): R1—SO2NHCO—A—X—R2  (I) wherein R1 is alky, alkenyl, alkynyl and the like; A is an optionally substitutedheteropolycyclic group except benzimidazolyl, indolyl, 4,7-dihydrobenzimidazolyland 2,3-dihydrobenzoxazinyl; X is alkylene, oxa, oxa(lower)alkylene and t ...


7

8
Noriko Oku, Chikaka Oku, Tomohiro Oku, Hiroshi Kayakiri, Yoshito Abe, Hitoshi Hamashima, Hitoshi Sawada, Naoki Ishibashi, Hiroyuki Setoi, Noritsugu Yamasaki, Takafumi Imoto, Takahiro Hiramura: Sulfonamide compounds and uses thereof as medicines. Fujisawa Pharmaceutical, Oblon Spivak McClelland Maier & Neustadt P C, May 10, 2005: US06890934

The present invention relates to a sulfonamide compound of the formula (I): wherein each symbol is as defined in the specification, a salt thereof, and a pharmaceutical composition containing same. This compound can be an effective agent for the prophylaxis and treatment of the diseases curable base ...


9

10